(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

3CI: CONCEPT TO CLINIC COMMERCIALIZING INNOVATION

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

3CI: CONCEPT TO CLINIC COMMERCIALIZING INNOVATION

ST13

US500000097694117

Class

41

Filing

97694117

Registration

7259741

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

12

Latest update

06/18/2025

Trademark type

Word

Nice classes

41

Filing date

11/28/2022

Registration date

01/02/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/02/2024

Last transaction

06/18/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

08/15/2022

First use in commerce

09/01/2022

Drawing code

4

Owner type

03

Owner location

Dana Point, CA

Examiner

BECHHOFER, YOCHEVED

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Lab2Market, PBC

Representatives

Mary T. Dowling, Esq. TOVELLA DOWLING, PC

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Education servicesproviding live and on-line coursesclasseslecturesseminarsworkshopstraining in the field of commercialization for medical innovation; Educational servicesconducting coursesclasseslecturesseminarsworkshopstraining in the field of commercialization for medical innovation and distribution of educational materials in connection therewith; Providing educational mentoring services and programs in the field of commercialization for medical innovation

Publications

History of USPTO decisions and trademark events.

12 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/11/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/11/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/11/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/02/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/02/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/17/2023

PUBO

PUBLISHED FOR OPPOSITION

10/17/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/27/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/13/2023

DOCK

ASSIGNED TO EXAMINER

09/07/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/20/2022

NWAP

NEW APPLICATION ENTERED

12/01/2022

Continuous trademark protection

Get notified about every new filing that threatens 3CI: CONCEPT TO CLINIC COMMERCIALIZING INNOVATION or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.